CHANP-201-PD

N/A

Report date: 2025/04/21 16:57:18

Base Information

Drug NameCHANP-201-PD

Drug Alias NameCHANP-201-PDCBT-NPC

ClassificationCell and gene therapy > Cell therapy > Somatic cell > Neural progenitor cell therapyCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionCell replacements

TargetsUpdating

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCHA Biotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCHA Biotech Co Ltd

Inactive CompaniesN/A

Active IndicationsParkinson Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A